Navigation Links
EntreMed Initiates Plans for China Office
Date:3/5/2012

actors, including: the risk that we may be unable to continue as a going concern as a result of our inability to raise sufficient capital for our operational needs; our history of losses and expectation of incurring continued losses; the risk that our stockholders may not approve our recent financing transaction and our ability to repay the indebtedness incurred in connection with issuance and sale of the convertible notes if such notes are not converted into shares of common stock; the possibility that we may be delisted from trading on the Nasdaq Capital Market; the volatility of our common stock; our inability to enter into strategic partnerships for the development, commercialization, manufacturing and distribution of our proposed product candidate; risks relating to the need for additional capital and the uncertainty of securing additional funding on favorable terms; declines in actual sales of Thalomid® resulting in reduced royalty payments; risks associated with our product candidates; any early-stage products under development; results in preclinical models are not necessarily indicative of clinical results; uncertainties relating to preclinical and clinical trials, including delays to the commencement of such trials; the lack of success in the clinical development of any of our products; dependence on third parties; and risks relating to the commercialization, if any, of our  proposed products (such as marketing, safety, regulatory, patent, product liability, supply, competition and other risks); and our ability to compete with larger, better financed biotechnology companies that may develop new approaches to the treatment of our targeted diseases or develop product candidates more advanced than ENMD-2076.  Such factors, among others, could have a material adverse effect upon our business, results of operations and financial condition.  We caution readers not to place undue reliance on any forward-looking statements, which only speak as
'/>"/>
SOURCE EntreMed, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
2. EntreMed Raises $20 Million to Support Clinical Development Program
3. EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198
4. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
5. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
6. EntreMed to Present at The New York Society of Security Analysts Industry Conference
7. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
8. EntreMed Commences Continuous Dosing Clinical Trial For MKC-1
9. EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program
10. EntreMed to Highlight ENMD-2076 Kinase Inhibitor at 2008 AACR Annual Meeting
11. EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/5hkm2f/medical_oxygen ... Oxygen Systems - Global Strategic Business Report" report ... worldwide markets for Medical Oxygen Systems in US$ Thousands ... Oxygen Cylinders & Regulators, and Oxygen Conserving Devices. The ... Canada , Japan , ...
(Date:4/17/2015)... 2015 Today, the Pharmaceutical Research and ... 12 biopharmaceutical companies as "We Work For Health ... and community service. Established in 2009, ... created by the biopharmaceutical industry to honor employees ... but have also shown an outstanding commitment to ...
(Date:4/17/2015)... , Apr. 16, 2015 Research and ... the addition of the "The Corporate Reputation ... - Global Edition " report to their ... a Patient Perspective, is now in its fourth ... results; published early 2015). For each annual Corporate ...
Breaking Medicine Technology:Medical Oxygen Systems - 2015 Global Strategic Business Report Featuring Leading Players, Caire, Invacare & Philips Respironics 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 3The Corporate Reputation of Pharma - The Global Patient Perspective in 2014 2
... EF Johnson Technologies, Inc. (Nasdaq: EFJI ), a ... results for the quarter ended September 30, 2009. Revenues ... was $1.6 million, or $(0.06) per diluted share, for the ... pleased with our orders and contract awards, the third quarter ...
... Inc. (NYSE: ZMH ; SIX: ZMH) announced today that ... unsecured notes in an underwritten public offering consisting of $500.0 ... 5.75% notes due 2039. The 10-year notes were priced to ... 30-year notes were priced at 135 basis points above their ...
Cached Medicine Technology:EF Johnson Technologies Announces Third Quarter Results 2EF Johnson Technologies Announces Third Quarter Results 3EF Johnson Technologies Announces Third Quarter Results 4EF Johnson Technologies Announces Third Quarter Results 5EF Johnson Technologies Announces Third Quarter Results 6EF Johnson Technologies Announces Third Quarter Results 7EF Johnson Technologies Announces Third Quarter Results 8Zimmer Holdings, Inc. Agrees to Sell $1 Billion of Senior Notes 2
(Date:4/19/2015)... has released a new blog post making weather predictions ... affect auto insurance premiums . , Bad ... premiums. In some Northern states like Wisconsin, due to ... other parts. The newly released blog post explains how ... and what impact, if any, it will have on ...
(Date:4/19/2015)... (PRWEB) April 19, 2015 The American ... up with PROSHRED Security (“PROSHRED”) to host its second ... to shred their personal documents in order to raise ... prevention. , The June 6th event is being held ... – 2pm local time. The time will vary at ...
(Date:4/19/2015)... Houston, Texas (PRWEB) April 19, 2015 ... is pleased to announce the publication of white paper ... Online Affair . As online media provides a ... whole new niche market specifically targeting adulterous spouses ... which an affair becomes as easy as shopping online. ...
(Date:4/19/2015)... April 19, 2015 Family and friends of ... Brains in Memory of Brad Baddeley event to honor ... Foundation. , Bowling for Brains is cheduled to take place ... Dudley Street in Lincoln, Nebraska. Participants may arrive at 12:30pm ... 3:00pm. , The cost is only $4 per game and ...
(Date:4/18/2015)... April 19, 2015 For some people, tattoos ... display for the rest of their lives, as they have ... and put in a great amount of thought on their ... they have outgrown them or simply want them removed for ... regret their tattoo, and in 2012-13 there was a 43 ...
Breaking Medicine News(10 mins):Health News:Bad Weather Can Cause Accidents and Affect Auto Insurance Prices! 2Health News:2015 Annual Nationwide "Shred Cancer" Shredding Event 2Health News:McCann Investigations Publishes White Paper Married, but Dating: The Rise of the Married Online Affair 2Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 2Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 3Health News:Dennis Dass, M.D. is Shattering the Past While Revealing the Future 2
... prostate cancer treated with a specialized type of ... fewer gastrointestinal complications compared to patients treated with ... study presented November 1, 2010, at the 52nd ... Oncology (ASTRO). , "With survivors living ...
... invasive bladder cancer allows 67 percent of people to be ... This compares to 54 percent of people who receive radiation ... presented at the plenary session, November 1, 2010, at the ... (ASTRO). , "The trial shows that this treatment offers improved ...
... October 25, 2010 The Life Sciences Discovery Fund (LSDF) ... Corporation (NASDAQ: OMER) to discover, develop, and commercialize new ... successful generation of proceeds through partnering and the sales ... the grant would be establishment of a new non-profit ...
... HealthDay Reporter , MONDAY, Oct. 25 (HealthDay News) -- New ... will start sleeping through the night between 2 and 4 ... however, is for the baby,s eight hours of slumber to ... "The most rapid changes in infant sleep were found ...
... immune system genes A team of ... Cambridge, United Kingdom, has shed new light on genetic ... common disorders of pregnancy, specifically recurrent miscarriage, preeclampsia, and ... initiation of a successful pregnancy is the invasion of ...
... pathway that, when blocked, significantly decreases the spread of ... at The University of Texas MD Anderson Children,s Cancer ... in mice decreased metastases in the lungs 15-fold. The ... Sunday in an oral presentation at the 42nd Congress ...
Cached Medicine News:Health News:Highly targeted radiation technique minimizes side effects of prostate cancer treatment 2Health News:Chemotherapy plus radiation prevents bladder cancer recurrences 2Health News:Life Sciences Discovery Fund to support drug discovery, foster new R&D initiative 2Health News:Life Sciences Discovery Fund to support drug discovery, foster new R&D initiative 3Health News:Most Babies Start Sleeping Through Night at 2 to 4 Months 2Health News:Most Babies Start Sleeping Through Night at 2 to 4 Months 3Health News:JCI table of contents: Oct. 25, 2010 2Health News:JCI table of contents: Oct. 25, 2010 3Health News:JCI table of contents: Oct. 25, 2010 4Health News:JCI table of contents: Oct. 25, 2010 5Health News:JCI table of contents: Oct. 25, 2010 6Health News:JCI table of contents: Oct. 25, 2010 7Health News:JCI table of contents: Oct. 25, 2010 8Health News:JCI table of contents: Oct. 25, 2010 9Health News:Researchers find pathway that drives spread of pediatric bone cancer in preclinical studies 2
... is the UK's market-leading system for ... pathology laboratories in the UK and ... addition, hundreds of pathology laboratories worldwide, ... Africa and the United States trust ...
... Our thawing systems are automated, easy to ... from the outside environment by flexible snap-seal ... bacterial or viral contamination of the water. ... the systems can also accommodate bags of ...
... QuickThaw Plasma Thawing Systems from Helmer use ... thaw times while ensuring the safety of your ... bag) models have dual baskets with independent controls ... ,The QuickThaw is also convenient to operate, ...
... Stent, a flexible, self-expanding nitinol design intended ... the biliary system, is now available from ... Food and Drug Administration. Incorporating the features ... stents successful around the world, the Zilver ...
Medicine Products: